CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.28B, above the global median of $1.18B
- FinancialsAltman Z-Score 5.62: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.12%
Annual Rate
INR 1.00Paid unknown
Payout Ratio
5.3%Sustainable
Last Ex-Dividend
Jul 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
122.47BINR1.28B · vs all stocks (USD)
Trailing P/E
42.08xRevenue (TTM)
45.04BINR469.36M · vs all stocks (USD)
Profit Margin
6.48%Beta
0.5810xvs all stocks
52-Week Change
81.21%vs all stocks
Forward Annual Dividend Yield
0.12%vs all stocks
Market Capitalization
122.47BINR1.28B · vs all stocks (USD)
Enterprise Value
110.76BINR1.15B · vs all stocks (USD)
Trailing P/E
42.08xForward P/E
23.44xPEG Ratio
0.7338xPrice to Sales (TTM)
2.72xPrice to Book (MRQ)
3.70xEnterprise to Revenue
2.46xEnterprise to EBITDA
20.04xGross Margin
44.68%Profit Margin
6.48%Operating Margin
11.45%Return on Assets (TTM)
4.68%Return on Equity (TTM)
7.66%Revenue (TTM)
45.04BINR469.36M · vs all stocks (USD)
Revenue per Share (TTM)
294.09INRUpdated Sep 29, 2026Quarterly Revenue Growth
13.90%Gross Profit (TTM)
18.51BINR192.87M · vs all stocks (USD)
EBITDA (TTM)
6.97BINR72.60M · vs all stocks (USD)
Net Income (TTM)
2.92BINR30.40M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
57.60%Operating Cash Flow (TTM)
11.81BINR123.09M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
2.55BINR26.59M · vs all stocks (USD)
Forward Annual Dividend Rate
1.00INRUpdated Sep 29, 2026Forward Annual Dividend Yield
0.12%vs all stocks
Trailing Annual Dividend Rate
0.00INRUpdated Sep 29, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
5.25%Minority Interest (Equity)
177.73MINRFY2026 · Mar 31, 2026Revenue
42.51BINRFY2026 · Mar 31, 2026Cost of Goods Sold
25.48BINRFY2026 · Mar 31, 2026Gross Profit
17.03BINRFY2026 · Mar 31, 2026Operating Income
3.74BINR38.97M · vs all stocks (USD)
Pre-tax Income
3.82BINRFY2026 · Mar 31, 2026Income Tax Expense
1.26BINRFY2026 · Mar 31, 2026Net Income
2.56BINRFY2026 · Mar 31, 2026EBIT
4.71BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
6.45BINRFY2026 · Mar 31, 2026Selling, General & Administrative
1.29BINRFY2026 · Mar 31, 2026Other Operating Expenses
4.01BINRFY2026 · Mar 31, 2026Non-operating Interest Income
1.10BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
886.22MINRFY2026 · Mar 31, 2026Minority Interests (P&L)
-12.09MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
10.92BINRFY2026 · Mar 31, 2026Free Cash Flow
8.70BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
3.86BINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
3.82BINRFY2026 · Mar 31, 2026Other Non-cash Items
-194.10MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-522.57MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
7.82BINRFY2026 · Mar 31, 2026Capital Expenditures
-2.23BINRFY2026 · Mar 31, 2026Net Acquisitions
-250.00KINRFY2026 · Mar 31, 2026Purchase of Investments
-7.46BINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-9.69BINRFY2026 · Mar 31, 2026Long-term Debt Payments
0.00INRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
592.99MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
592.99MINRFY2026 · Mar 31, 2026Shares Outstanding
153.10MSharesUpdated Sep 29, 2026Float Shares
34.65MSharesUpdated Sep 29, 2026% Held by Insiders
84.93%vs all stocks
% Held by Institutions
12.49%vs all stocks
Total Cash (MRQ)
16.81BINR175.14M · vs all stocks (USD)
Total Cash per Share (MRQ)
109.77INRUpdated Sep 29, 2026Total Debt (MRQ)
1.92BINR19.98M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0576xCurrent Ratio (MRQ)
3.25xBook Value per Share (MRQ)
216.41INRUpdated Sep 29, 2026Total Assets
54.47BINR567.63M · vs all stocks (USD)
Total Current Assets
35.60BINRFY2026 · Mar 31, 2026Total Liabilities
21.16BINRFY2026 · Mar 31, 2026Total Non-current Assets
18.87BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
10.21BINRFY2026 · Mar 31, 2026Total Current Liabilities
10.95BINRFY2026 · Mar 31, 2026Cash
539.84MINRFY2026 · Mar 31, 2026Cash Equivalents
3.32BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
3.86BINRFY2026 · Mar 31, 2026Other Short-term Investments
12.95BINRFY2026 · Mar 31, 2026Accounts Receivable
7.97BINRFY2026 · Mar 31, 2026Inventory
7.56BINRFY2026 · Mar 31, 2026Accounts Payable
6.02BINRFY2026 · Mar 31, 2026Short-term Debt
1.15BINRFY2026 · Mar 31, 2026Other Current Liabilities
10.00KINRFY2026 · Mar 31, 2026Long-term Debt
768.44MINRFY2026 · Mar 31, 2026Other Non-current Liabilities
208.98MINRFY2026 · Mar 31, 2026Common Stock (Book)
306.21MINRFY2026 · Mar 31, 2026Retained Earnings
20.86BINRFY2026 · Mar 31, 2026Total Shareholders' Equity
33.31BINR347.14M · vs all stocks (USD)
52-Week Low
409.30INRUpdated Sep 29, 202652-Week High
838.80INRUpdated Sep 29, 202652-Week Change
81.21%vs all stocks
Beta
0.5810xvs all stocks
50-Day MA
740.22INRUpdated Sep 29, 2026200-Day MA
571.36INRUpdated Sep 29, 2026Avg 10-Day Volume
317.85KSharesUpdated Sep 29, 2026Avg 30-Day Volume
338.57KSharesUpdated Sep 29, 2026Diluted EPS (TTM)
19.01INRUpdated Sep 29, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.45Profit Margin: 0.06
Financial Health
Altman Z-Score 5.62: safe zoneNotable
Altman Z-Score: 5.62
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.28B, above the global median of $1.18BNotable
Market cap (USD): 1,276,301,479.261Global Median: 1,180,223,658.953
Levered free cash flow is $26.59M, above the global median of $18.73MNotable
Levered free cash flow (USD): 26,593,141.48Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Damora Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Yizhong Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Yahong Meditech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Immatics N.V.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Bicara Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Xianju Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Changzhou Qianhong Biopharma Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Hisun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sinocare Inc.
Tier 1ProductionApproval-Gated PipelineRule
Integra LifeSciences Holdings Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow